Director Picks Up PTAB Denial Over Hormone Treatment
The director of the U.S. Patent and Trademark Office has agreed to review a Patent Trial and Appeal Board decision that refused to reassess a biotechnology maker's patent related to the...To view the full article, register now.
Already a subscriber? Click here to view full article